Stockholm, December 19, 2016 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Acarix AB’s shares (short name: ACARIX) commenced today on Nasdaq First North Premier in Stockholm. Acarix belongs to the health care sector and is the 88th company to be admitted to trading on Nasdaq’s Nordic markets* in 2016.
Acarix is a Swedish/Danish commercial stage medical device company working to revolutionize cardiac diagnostics. The company has developed an acoustic test device and software algorithm, CADScor System, designed to help doctors assess patients’ risk of Coronary Artery Disease (CAD), a condition affecting more than 120 million people worldwide. Acarix was established as a spin-out from Coloplast A/S in 2009. For more information, please visit www.acarix.com.
”The listing on Nasdaq First North Premier marks yet another milestone for our company and the great interest from the investment community confirms a high level of confidence in our strategy,” said Søren Rysholt Christiansen, CEO of Acarix. “The IPO will help secure the execution of our commercialization strategy and anticipated launch of our CADScor System in Q2 2017. We are confident that the CADScor System will be a valuable tool in healthcare for the benefit of patients, payers and physicians alike.”
“We welcome Acarix to Nasdaq First North Premier,” said Adam Kostyál, senior vice president and head of European listings at Nasdaq. “Acarix operates in an exciting field and will make a great addition to our health care sector. We look forwarding to supporting Acarix for many years to come.”
Acarix AB has appointed Wildeco Ekonomisk Information AB as the Certified Adviser.
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
About Nasdaq First North
Nasdaq First North is regulated as a multilateral trading facility, operated by the different exchanges within Nasdaq Nordic (Nasdaq First North Denmark is regulated as an alternative marketplace). It does not have the legal status as an EU-regulated market. Companies at Nasdaq First North are subject to the rules of Nasdaq First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of $10.0 trillion and approximately 18,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact|
|+46 73 449 78 07|